These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16224249)

  • 1. Muscle regeneration through myostatin inhibition.
    Wagner KR
    Curr Opin Rheumatol; 2005 Nov; 17(6):720-4. PubMed ID: 16224249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis.
    Zhu J; Li Y; Shen W; Qiao C; Ambrosio F; Lavasani M; Nozaki M; Branca MF; Huard J
    J Biol Chem; 2007 Aug; 282(35):25852-63. PubMed ID: 17597062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice.
    Nakatani M; Takehara Y; Sugino H; Matsumoto M; Hashimoto O; Hasegawa Y; Murakami T; Uezumi A; Takeda S; Noji S; Sunada Y; Tsuchida K
    FASEB J; 2008 Feb; 22(2):477-87. PubMed ID: 17893249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and neural control of follistatin versus myostatin genes during regeneration of mouse soleus.
    Armand AS; Della Gaspera B; Launay T; Charbonnier F; Gallien CL; Chanoine C
    Dev Dyn; 2003 Jun; 227(2):256-65. PubMed ID: 12761853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting myostatin for therapies against muscle-wasting disorders.
    Tsuchida K
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):487-94. PubMed ID: 18600566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Proteomic and Transcriptomic Analysis of Follistatin-Induced Skeletal Muscle Hypertrophy.
    Barbé C; Bray F; Gueugneau M; Devassine S; Lause P; Tokarski C; Rolando C; Thissen JP
    J Proteome Res; 2017 Oct; 16(10):3477-3490. PubMed ID: 28810121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of myostatin and bone morphogenetic proteins in muscular disorders.
    Tsuchida K
    Expert Opin Biol Ther; 2006 Feb; 6(2):147-54. PubMed ID: 16436040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological inhibition of myostatin/TGF-β receptor/pSmad3 signaling rescues muscle regenerative responses in mouse model of type 1 diabetes.
    Jeong J; Conboy MJ; Conboy IM
    Acta Pharmacol Sin; 2013 Aug; 34(8):1052-60. PubMed ID: 23770987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis.
    Zhu J; Li Y; Lu A; Gharaibeh B; Ma J; Kobayashi T; Quintero AJ; Huard J
    Am J Pathol; 2011 Aug; 179(2):915-30. PubMed ID: 21689628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myostatin: a therapeutic target for skeletal muscle wasting.
    Roth SM; Walsh S
    Curr Opin Clin Nutr Metab Care; 2004 May; 7(3):259-63. PubMed ID: 15075916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The function of Myostatin and strategies of Myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle.
    Patel K; Amthor H
    Neuromuscul Disord; 2005 Feb; 15(2):117-26. PubMed ID: 15694133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle regeneration in the prolonged absence of myostatin.
    Wagner KR; Liu X; Chang X; Allen RE
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2519-24. PubMed ID: 15699335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myostatin blockade: a new way to enhance skeletal muscle repair in old age?
    Yablonka-Reuveni Z
    Mol Ther; 2007 Aug; 15(8):1407-9. PubMed ID: 17646837
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific targeting of TGF-β family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease.
    Chen JL; Walton KL; Hagg A; Colgan TD; Johnson K; Qian H; Gregorevic P; Harrison CA
    Proc Natl Acad Sci U S A; 2017 Jun; 114(26):E5266-E5275. PubMed ID: 28607086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic potential of agents that inactivate myostatin.
    Bishop A; Kambadur R; Sharma M
    Expert Opin Investig Drugs; 2005 Sep; 14(9):1099-106. PubMed ID: 16144494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice.
    Benabdallah BF; Bouchentouf M; Rousseau J; Bigey P; Michaud A; Chapdelaine P; Scherman D; Tremblay JP
    Cell Transplant; 2008; 17(3):337-50. PubMed ID: 18522236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myostatin, a negative regulator of muscle mass: implications for muscle degenerative diseases.
    Tobin JF; Celeste AJ
    Curr Opin Pharmacol; 2005 Jun; 5(3):328-32. PubMed ID: 15907921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myostatin in muscle growth and repair.
    Sharma M; Langley B; Bass J; Kambadur R
    Exerc Sport Sci Rev; 2001 Oct; 29(4):155-8. PubMed ID: 11688787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease.
    Rodino-Klapac LR; Haidet AM; Kota J; Handy C; Kaspar BK; Mendell JR
    Muscle Nerve; 2009 Mar; 39(3):283-96. PubMed ID: 19208403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of myostatin and follistatin in Mdx mice, an animal model for muscular dystrophy.
    Abe S; Soejima M; Iwanuma O; Saka H; Matsunaga S; Sakiyama K; Ide Y
    Zoolog Sci; 2009 May; 26(5):315-20. PubMed ID: 19715499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.